There is escalating evidence that circulating miR-21 might be a valuable biomarker in various
Myelodysplastic syndromes (MDS) are a heterogeneous team of clonal problems characterized by bone marrow failure, dysplasia of 1 or much…
Myelodysplastic syndromes (MDS) are a heterogeneous team of clonal problems characterized by bone marrow failure, dysplasia of 1 or much…